Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 142,096 shares at $38.33 ($5.6M) on 2018-07-02, disclosed to the SEC on 2018-07-05.
Open-market sale of $5.6M BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.33 | 19,599 | $751K | 13.4% |
| 2 | $38.33 | 19,599 | $751K | 13.4% |
| 3 | $38.78 | 1,401 | $54K | 1.0% |
| 4 | $38.78 | 1,401 | $54K | 1.0% |
| 5 | $40.05 | 26,901 | $1.1M | 19.2% |
| 6 | $40.05 | 26,901 |
| $1.1M |
| 19.2% |
| 7 | $40.04 | 23,147 | $927K | 16.5% |
| 8 | $40.04 | 23,147 | $927K | 16.5% |
| Total | $39.55 avg | 142,096 | $5.6M | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |